These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39094775)

  • 1. The Susceptibility of Escherichia Coli to Antibiotic Treatment for Pediatric Patients With Febrile Urinary Tract Infections in the Bratislava Region.
    Pitekova B; Konopásek P; Babelova M; Gecz J; Hlasna K; Breza J; Barton P; Zieg J
    Klin Padiatr; 2024 Aug; ():. PubMed ID: 39094775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third-Generation Cephalosporin Resistance and Associated Discordant Antibiotic Treatment in Emergency Department Febrile Urinary Tract Infections.
    Mark DG; Hung YY; Salim Z; Tarlton NJ; Torres E; Frazee BW
    Ann Emerg Med; 2021 Sep; 78(3):357-369. PubMed ID: 33781606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility patterns of escherichia coli in children and adults with urinary tract infections.
    Mykhalko YO
    Wiad Lek; 2018; 71(2 pt 1):306-310. PubMed ID: 29729161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etiologies of community-onset urinary tract infections requiring hospitalization and antimicrobial susceptibilities of causative microorganisms.
    Chiu CC; Lin TC; Wu RX; Yang YS; Hsiao PJ; Lee Y; Lin JC; Chang FY
    J Microbiol Immunol Infect; 2017 Dec; 50(6):879-885. PubMed ID: 28087318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Features of Febrile Urinary Tract Infection Caused by Extended-spectrum Beta-lactamase-producing Escherichia Coli in Children.
    Ohnishi T; Mishima Y; Takizawa S; Tsutsumi K; Amemiya A; Akiyama N; Kanna Y; Asato S; Tomita M; Ikemiyagi M; Shikoro N; Nakazawa M; Kurihara N; Kamimaki I
    Keio J Med; 2020 Jun; 69(2):43-47. PubMed ID: 31474677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients].
    Wagenlehner FM; Schmiemann G; Hoyme U; Fünfstück R; Hummers-Pradier E; Kaase M; Kniehl E; Selbach I; Sester U; Vahlensieck W; Watermann D; Naber KG
    Urologe A; 2011 Feb; 50(2):153-69. PubMed ID: 21312083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance among bacteria isolated from urinary tract infections in females in Namibia, 2016-2017.
    Haindongo EH; Funtua B; Singu B; Hedimbi M; Kalemeera F; Hamman J; Vainio O; Hakanen AJ; Vuopio J
    Antimicrob Resist Infect Control; 2022 Feb; 11(1):33. PubMed ID: 35151360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: A French prospective multicenter study.
    Madhi F; Jung C; Timsit S; Levy C; Biscardi S; Lorrot M; Grimprel E; Hees L; Craiu I; Galerne A; Dubos F; Cixous E; Hentgen V; Béchet S; ; Bonacorsi S; Cohen R
    PLoS One; 2018; 13(1):e0190910. PubMed ID: 29370234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of urinary nitrites is a significant predictor of pediatric urinary tract infection susceptibility to first- and third-generation cephalosporins.
    Weisz D; Seabrook JA; Lim RK
    J Emerg Med; 2010 Jul; 39(1):6-12. PubMed ID: 18757159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility patterns of uropathogens identified in hospitalised children with community-acquired urinary tract infections in Thrace, Greece.
    Mantadakis E; Vouloumanou EK; Panopoulou M; Tsouvala E; Tsalkidis A; Chatzimichael A; Falagas ME
    J Glob Antimicrob Resist; 2015 Jun; 3(2):85-90. PubMed ID: 27873675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimicrobial resistance patterns in pediatric febrile urinary tract infection and empirical antibacterial therapy. An epidemiological study in secondary and tertiary care centers in the north-east of France in 2019-2020].
    Arabska M; Girardin ML; Long L; Grillon A; Zaloszyc A
    Nephrol Ther; 2022 Apr; 18(2):129-135. PubMed ID: 35260346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic treatment and antimicrobial resistance in children with urinary tract infections.
    Vazouras K; Velali K; Tassiou I; Anastasiou-Katsiardani A; Athanasopoulou K; Barbouni A; Jackson C; Folgori L; Zaoutis T; Basmaci R; Hsia Y
    J Glob Antimicrob Resist; 2020 Mar; 20():4-10. PubMed ID: 31252156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-Acquired Uropathogenic
    Carmona-Cartaya Y; Hidalgo-Benito M; Borges-Mateus LM; Pereda-Novales N; González-Molina MK; Quiñones-Pérez D
    MEDICC Rev; 2022 May; 24(2):20-25. PubMed ID: 35648059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Febrile Urinary Tract Infection With or Without Bacteraemia in Children: A French Case-Control Retrospective Study.
    Goeller C; Desmarest M; Garraffo A; Bonacorsi S; Gaschignard J
    Front Pediatr; 2020; 8():237. PubMed ID: 32548080
    [No Abstract]   [Full Text] [Related]  

  • 15. Aminoglycosides Monotherapy as First-Line Treatment for Febrile Urinary Tract Infection in Children.
    Poey N; Madhi F; Biscardi S; Béchet S; Cohen R
    Pediatr Infect Dis J; 2017 Nov; 36(11):1104-1107. PubMed ID: 28498305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Febrile urinary tract infection in children: ampicillin and trimethoprim insufficient as empirical mono-therapy.
    Prelog M; Schiefecker D; Fille M; Wurzner R; Brunner A; Zimmerhackl LB
    Pediatr Nephrol; 2008 Apr; 23(4):597-602. PubMed ID: 18193296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the 20-year evolution of antimicrobial resistance patterns of pediatric urinary tract infections in a single center.
    Dejonckheere Y; Desmet S; Knops N
    Eur J Pediatr; 2022 Sep; 181(9):3271-3281. PubMed ID: 35739294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E. coli, K. pneumoniae and K. oxytoca community-acquired infections susceptibility to cephalosporins and other antimicrobials in Lebanon.
    Moghnieh RA; Musharrafieh UM; Husni RN; Abboud E; Haidar M; Abboud E; Abou Shakra D
    J Med Liban; 2014; 62(2):107-12. PubMed ID: 25011373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteria Causing Community-Acquired Urinary Tract Infections and Their Antibiotic Susceptibility Patterns in Outpatients Attending at a State Hospital in Turkey.
    Öztürk R; Tazegul G
    Cureus; 2021 Sep; 13(9):e17753. PubMed ID: 34659966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT.
    Harding C; Chadwick T; Homer T; Lecouturier J; Mossop H; Carnell S; King W; Abouhajar A; Vale L; Watson G; Forbes R; Currer S; Pickard R; Eardley I; Pearce I; Thiruchelvam N; Guerrero K; Walton K; Hussain Z; Lazarowicz H; Ali A
    Health Technol Assess; 2022 May; 26(23):1-172. PubMed ID: 35535708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.